In oligodendrocytes, a sex‐dimorphic alteration was observed for FKBP5 (FK506 binding protein 5), with increased levels in male AD (FDR = 1.17E‐295) and decreased expression in female patients (FDR = 1.06E‐294). Here, FKBP5 is linked to Alzheimer disease.